Viral Haemorrhagic Fever - Revision history

Frances.Sarkari@anthonynolan.org at 16:51, 16 January 2024

2024-01-16T16:51:33Z

2020-10-20T08:53:00Z

version

2020-10-20T08:52:33Z

Guidance

2020-10-20T08:51:57Z

Guidance

2020-10-20T08:50:51Z

Guidance

2020-10-20T08:50:19Z

Guidance

2020-10-20T08:47:06Z

Explanation of Condition

2018-06-18T09:30:13Z

2018-06-18T09:29:52Z

2018-06-18T09:29:19Z

← Older revision		Revision as of 16:51, 16 January 2024
Line 64:		Line 64:

	See if relevant; The Geographical Disease Risk Index for countries with a current endemic Viral Haemorrhagic Fever risk.		See if relevant; The Geographical Disease Risk Index for countries with a current endemic Viral Haemorrhagic Fever risk.
		+
		+	==Pseudonyms or Related Conditions==
		+	VHF

	==Examples of viral haemorrhagic fever==		==Examples of viral haemorrhagic fever==

@@ Line 76: / Line 76: @@
 ==version==
-Version 1.0.
+Version 2.0.
-June 2016
+October 2020

@@ Line 16: / Line 16: @@
 For up-to-date guidance also see [[http://www.transfusionguidelines.org/dsg/bm]]
 '''1.Affected Individual'''
@@ Line 24: / Line 25: @@
 a)	Has ever been infected.
 '''2.Contact or travel to endemic country'''

@@ Line 32: / Line 32: @@
 a)	Was present in an area during an active outbreak
 b)	Under investigation for viral haemorrhagic fever
 c)	Has been in contact with an individual who was present in an area during and active outbreak.
 d)	Was in contact with an individual infected with, or as under investigation for viral haemorrhagic fever
 e)	Less than six months after return to the UK from an endemic area when there was no active outbreak
 Under exceptional circumstances, the donor may be accepted subject to individual risk assessment. Refer to designated medical officer. See additional information section.
@@ Line 44: / Line 49: @@
 a)	More than 6 months after return to the UK from an endemic area when there was no active outbreak at the time of visit.
 b)	If the individual, or the contact person, under investigation had viral haemorrhagic fever infection excluded as a diagnosis.
 '''
 .Sexual Partner of Affected Individual'''
 Obligatory

@@ Line 16: / Line 16: @@
 For up-to-date guidance also see [[http://www.transfusionguidelines.org/dsg/bm]]
 '''
-.Affected Individual'''
+'''1.Affected Individual'''
 Obligatory

@@ Line 16: / Line 16: @@
 For up-to-date guidance also see [[http://www.transfusionguidelines.org/dsg/bm]]
-Unacceptable:
+Must not donate if;
-a) Was present in an area during an active outbreak
+a)	Has ever been infected.
-b) Under investigation for viral haemorrhagic fever
+'''2.Contact or travel to endemic country'''
-c) Has been in contact with an individual who was present in an area
+Obligatory
-d) Was in contact with an individual infected with, or was under
+Must not donate if;
-e) less than six months after return to UK from an endemic area when
+a)	Was present in an area during an active outbreak
-there was no active outbreak.
+b)	Under investigation for viral haemorrhagic fever
-Acceptable:
+Discretionary;
-a. If more than 6 months after return to UK from an endemic area when
+Accept it;
-b. If the individual, or the contact person, under investigation had viral
+a)	More than 6 months after return to the UK from an endemic area when there was no active outbreak at the time of visit.
-haemorrhagic fever infection excluded as diagnosis.
+b)	If the individual, or the contact person, under investigation had viral haemorrhagic fever infection excluded as a diagnosis.
 ==Examples of viral haemorrhagic fever==

@@ Line 9: / Line 9: @@
 ==Explanation of Condition==
-Viral haemorrhagic fever.
+These infections have very high death rates and there is evidence that the virus may persist for some time after recovery. The 2014-2016 outbreak of Ebola in West Africa has increased understanding about the persistence of the virus in affected individuals and the number of asymptomatic individuals who may be able to transmit the virus to others.
+There is no routine screening test for EBOV currently available. There is an option to test donors serologically for the presence of anti-EBOV (antibodies) two months after the exposure event if a test becomes available. A reactive test would result in permanent deferral, a negative test would allow donation to proceed. Designated medical officers may seek expert advice where necessary, under exceptional circumstances.
 ==Guidance==

← Older revision		Revision as of 09:30, 18 June 2018
Line 15:		Line 15:

	For up-to-date guidance also see [[http://www.transfusionguidelines.org/dsg/bm]]		For up-to-date guidance also see [[http://www.transfusionguidelines.org/dsg/bm]]
		+

	Unacceptable:		Unacceptable: